Kropff, M., Goranov, S., Baylon, H. Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: Results from optimum, a randomized trial,
, .
Kropff, M., Goranov, S., Baylon, H. .
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: Results from optimum, a randomized trial.
: , .
Kropff, M., Goranov, S., Baylon, H. ()
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: Results from optimum, a randomized trial,
:
Kropff, M.,
Goranov, S., &
Baylon, H.
().
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: Results from optimum, a randomized trial. Haematologica; Haematologica.